2. Cell Cycle/DNA Damage
    Anti-infection
    Autophagy
    Apoptosis
  3. DNA/RNA Synthesis
    Fungal
    Autophagy
    Ferroptosis
    Antibiotic
  4. Cycloheximide

Cycloheximide (Synonyms: Actidione; Naramycin A)

目录号: HY-12320 纯度: 99.86%
产品使用指南

Cycloheximide (Naramycin A) 是一种抗真菌 (antifungal) 抗生素，是真核生物蛋白质合成 (protein synthesis) 的抑制剂，抑制体内蛋白质合成和 RNA 合成的 IC50 值分别为 532.5 nM 和 2880 nM。Cycloheximide 可抑制铁死亡 (ferroptosis) 并抑制自噬 (autophagy)。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Cycloheximide Chemical Structure

Cycloheximide Chemical Structure

CAS No. : 66-81-9

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 价格 是否有货 数量
200 mg ￥500 In-stock
500 mg ￥700 In-stock

* Please select Quantity before adding items.

Customer Review

注册 MCE会员 并 完成审核
即刻享有 哈根达斯、星巴克、KFC、百果园 等专属礼券

Top Publications Citing Use of Products

MCE 顾客使用本产品发表的科研文献

    Cycloheximide purchased from MCE. Usage Cited in: Antioxid Redox Signal. 2019 May 20;30(15):1831-1848.

    Nrf2 and Keap1 degradation in NIH-3T3 cells when protein synthesis is inhibited by 50 μM Cycloheximide (n=3).

    Cycloheximide purchased from MCE. Usage Cited in: Cell Death Dis. 2018 May 22;9(6):604.

    AGS cells transfected with HA-tagged SQSTM1 plasmid, are treated with 25 μg/mL Cycloheximide (CHX) over a 240-min time period or treated with 100 μg/mL PPI for 48 h in pH 7.4 conditions, and then followed by 25 μg/mL CHX over a 240-min time period.

    Cycloheximide purchased from MCE. Usage Cited in: Chem Biol Interact. 2018 Mar 1;283:59-74.

    The expression levels of apoptosis-associated proteins after treatment with morusin or tumor necrosis factor-alpha (TNF-α)/Cycloheximide (CHX). A2780 cells are incubated with the indicated concentrations of morusin or TNF-α (50 ng/mL)/CHX (50 μM) for 24 h. GAPDH is used as a loading control in western blot analysis.

    Cycloheximide purchased from MCE. Usage Cited in: Chem Biol Interact. 2018 Mar 1;283:59-74.

    The expression levels of apoptosis-associated proteins after treatment with morusin or tumor necrosis factor-alpha (TNF-α)/Cycloheximide (CHX). SKOV-3 cells are incubated with the indicated concentrations of morusin or TNF-α (50 ng/mL)/CHX (50 μM) for 24 h. GAPDH is used as a loading control in western blot analysis.

    Cycloheximide purchased from MCE. Usage Cited in: Oncotarget. 2016 May 10;7(19):27176-84.

    PIG3 silencing does not affect the degradation of HIF-1α protein under hypoxia. Forty-eight hours after transfection with PIG3-siRNA or negative control siRNA, CAKI cells are pretreated under hypoxia for 4 h followed by treatment with 100 μg/mL Cycloheximide (CHX) to block protein synthesis for the indicated times. The mean values from two experiments are connected by the lines. Protein levels are analyzed by Immunoblotting, GAPDH is employed a loading control. All the experiments above are cond

    Cycloheximide purchased from MCE. Usage Cited in: Biochem Biophys Res Commun. 2017 Sep 2;490(4):1168-1175.

    SR-B1 protein is degraded by proteasome pathway. (A) SR-B1 is degraded in a CHX dose-dependent manner in CHO-K1 cells. (B) Time course of SR-B1 degradation in CHO-K1 cells treated with CHX.

    Cycloheximide purchased from MCE. Usage Cited in: Cell Death Dis. 2017 Sep 14;8(9):e3048.

    Cells are treated with CHX in the presence or absence of CQ and results show that the decrease NDRG1 observed after CHX treatment is partially recovered upon co-treatment with CHX and CQ.

    Cycloheximide purchased from MCE. Usage Cited in: J Hematol Oncol. 2018 Feb 23;11(1):26.

    Immunoblotting analysis of HOXB13 in MCF-7 cells time-dependently treated with 100 μg/mL Cycloheximide (CHX) after being transiently transfected with the indicated plasmids.

    Cycloheximide purchased from MCE. Usage Cited in: J Virol. 2018 Apr 27;92(10). pii: e00238-18.

    (A) PK15 cells are transfected with Flag-ORF4 for 24 h, and then treated with CHX for 0, 3, 6, 9, 12, and 15 h respectively. (B) PK15 cells are transfected with Flag-ORF4 for 24 h, and then exposed to both CHX and MG132 for 9h.

    Cycloheximide purchased from MCE. Usage Cited in: Oncotarget. 2018 Jan 4;9(20):15239-15251.

    Protein biosynthesis in MCF-7 cells is blocked with 100 μg/mL of Cycloheximide (CHX). MRTF-A protein levels in cells with or without LiCl co-treatment are measured with Western-blot at different time points.

    Cycloheximide purchased from MCE. Usage Cited in: Cell Death Dis. 2018 May 3;9(5):519.

    MCF-7 cells transfected with pIRES2-EGFP-3Flag/BRD7 or pIRES2-EGFP for 24 h and treated with CoCl2 (150 μM) for 24 h. Then the cells are incubated with 50 μg/mL Cycloheximide (CHX) for the indicated periods of time (0, 1, 3, 6 h). Lysates are harvested from the cells and analyzed by western blotting.

    Cycloheximide purchased from MCE. Usage Cited in: Oncotarget. 2018 Jan 4;9(20):15239-15251.

    Protein biosynthesis in MCF-7 cells is blocked with 100 μg/mL of Cycloheximide (CHX). MRTF-A protein levels in cells with or without LiCl co-treatment are measured with Western-blot at different time points.

    Cycloheximide purchased from MCE. Usage Cited in: EBioMedicine. 2018 Aug;34:243-255.

    Protein synthesis is inhibited by Cycloheximide (Cyclo).

    Cycloheximide purchased from MCE. Usage Cited in: Oncol Lett. 2018 Nov;16(5):5900-5906.

    pVHL interacts with NEK8 and promotes NEK8 degradation through the proteasome ubiquitination signaling pathway.

    Cycloheximide purchased from MCE. Usage Cited in: Autophagy. 2018;14(12):2155-2170.

    Representative western blots show TP53 expression in untreated and Sunitinib-treated primary colon cancer cells.

    Cycloheximide purchased from MCE. Usage Cited in: Cell Death Dis. 2018 Oct 12;9(10):1046.

    Cycloheximide (CHX) assay is performed to investigate the effects of CIRBP on HIF-1α protein stability.

    Cycloheximide purchased from MCE. Usage Cited in: Biochem Biophys Res Commun. 2019 Feb 12;509(3):797-802.

    Western analysis of NEK1 and VHL protein expression in the treatment such as CHX.

    Cycloheximide purchased from MCE. Usage Cited in: Virology. 2019 Apr;530:51-58.

    A549 cells are mock infected or infected with H1N1 at an MOI of 1. At 22 h p.i., cells are treated with DMOG for 2 h and then exposed to 50 μg/mL CHX. Cells are harvested at indicated time points after CHX addition and HIF-1α levels were measured by western blotting.

    Cycloheximide purchased from MCE. Usage Cited in: J Exp Clin Cancer Res. 2019 Feb 26;38(1):101.

    FBX022 ubiquitinates p21 via the F-box domain HLF and Hep3B are treated with CHX (10 μM), collected at the indicated time points, and immunoblotted for FBXO22, p21 and GAPDH. Quantification of the p21 levels relative to GAPDH expression is shown.

    Cycloheximide purchased from MCE. Usage Cited in: J Exp Clin Cancer Res. 2019 Feb 15;38(1):83.

    Western blot analysis of 97-L and 97-H cells incubated with 100 μM CHX in the absence or presence of JQ1.

    • 生物活性

    • 实验参考方法

    • 纯度 & 产品资料

    • 参考文献

    生物活性

    Cycloheximide (Naramycin A), an antifungal antibiotic, is an eukaryote protein synthesis inhibitor, with IC50s of 532.5 nM and 2880 nM for protein synthesis and RNA synthesis in vivo, respectively. Cycloheximide suppresses ferroptosis and inhibits autophagy[1].

    IC50 & Target

    IC50: 532.5 nM (protein synthesis), 2.88 μM (RNA synthesis)[1]
    体外研究
    (In Vitro)

    Cycloheximide (CHX) is the most common laboratory reagent used to inhibit protein synthesis. Cycloheximide has been shown to block the elongation phase of eukaryotic translation. Cycloheximide binds the ribosome and inhibits eEF2-mediated translocation. Surprisingly, Cycloheximide allows one complete translocation cycle to proceed before halting any further elongation. Cycloheximide has been speculated that Cycloheximide requires an E-site bound deacylated tRNA for activity[1].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.
    体内研究
    (In Vivo)

    The mice receive Cycloheximide injections at 30, 60, or 120 mg/kg prior to training with a 200 µA shock. There is a significant effect of Cycloheximide on latencies on the memory test trials (P<0.001). In saline controls, this shock level results in latencies on the test trial that are significantly higher than those at training. Injections of the lowest dose of Cycloheximide tested, 30 mg/kg, results in latencies on the test trial that are significantly higher than those seen in the saline control group. Mice receiving either of the two higher doses of Cycloheximide has latencies on the test trial that are comparable to those of the saline group, i.e., the higher doses neither enhanced nor impaired memory under these conditions, resulting in an inverted-U dose-response curve for Cycloheximide enhancement of memory[2]. Infarct volume, as measured by morphometric analysis of infarct areas with triphenyl tetrazolium chloride (TTC), is significantly reduced by 92% and 61% when Cycloheximide is given 0 or 6 hr after HI respectively, but shows an insignificant trend in infarct reduction if Cycloheximide is administered 12 hr after hypoxia-ischemia (HI) compared to the HI control group, and no protective effect is observed when administration is delayed until 24 hr after HI[3].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.
    分子量

    281.35

    Formula

    C₁₅H₂₃NO₄
    CAS 号
    中文名称

    放线菌酮
    运输条件

    Room temperature in continental US; may vary elsewhere.
    储存方式

    4°C, protect from light

    *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
    溶解性数据
    In Vitro: 

    DMSO : 125 mg/mL (444.29 mM; Need ultrasonic)

    H2O : 20 mg/mL (71.09 mM; Need ultrasonic and warming)

    配制储备液
    浓度 溶剂体积 质量 1 mg 5 mg 10 mg
    1 mM 3.5543 mL 17.7715 mL 35.5429 mL
    5 mM 0.7109 mL 3.5543 mL 7.1086 mL
    10 mM 0.3554 mL 1.7771 mL 3.5543 mL
    *

    请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
    储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

    In Vivo:

    请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

    ——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用； 以下溶剂前显示的百
    分比是指该溶剂在您配制终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

    • 1.

      请依序添加每种溶剂： 10% DMSO    40% PEG300    5% Tween-80    45% saline

      Solubility: ≥ 2.08 mg/mL (7.39 mM); Clear solution

      此方案可获得 ≥ 2.08 mg/mL (7.39 mM，饱和度未知) 的澄清溶液。

      以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。

      将 0.9 g 氯化钠，完全溶解于 100 mL ddH₂O 中，得到澄清透明的生理盐水溶液
    • 2.

      请依序添加每种溶剂： 10% DMSO    90% (20% SBE-β-CD in saline)

      Solubility: ≥ 2.08 mg/mL (7.39 mM); Clear solution

      此方案可获得 ≥ 2.08 mg/mL (7.39 mM，饱和度未知) 的澄清溶液。

      以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中，混合均匀。

      将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中，再用生理盐水定容至 10 mL，完全溶解，澄清透明
    • 3.

      请依序添加每种溶剂： 10% DMSO    90% corn oil

      Solubility: ≥ 2.08 mg/mL (7.39 mM); Clear solution

      此方案可获得 ≥ 2.08 mg/mL (7.39 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。

      以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。

    *以上所有助溶剂都可在 MCE 网站选购。
    参考文献
    Cell Assay
    [1]

    To test cell proliferation, 3000-5000 cells (HeLa, HTB1 and HEK 293T cells; Jurkat, BT 474, HCC 1395, HCC 1937, HCC 2218 and MDA MB231 cells; MCF 10A) per well are plated in a 96-well plate and allowed to adhere overnight. Cycloheximide dissolved in DMSO at the indicated concentrations (0.1 nM-1000μM) are then added and cells are incubated for a further 24 h. [3H]-thymidine is added at 1 μCi per well and incubation is continued for an additional 7 h. Cells are washed twice with PBS and then trypsinized before they are collected with a Tomtec harvester and bound to GF/C filter mats. Thymidine uptake is then measured by scintillation counting[1].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.
    Animal Administration
    [2][3]

    Mice[2]
    Male ICR mice (approximately 2 months old) are used in this experiment. Cycloheximide is administered IP at concentrations of 0 (saline controls), 30, 60, or 120 mg/kg. Cycloheximide injections are administered 30 min prior to training. The 120 mg/kg dose is commonly used to study amnesia in mice. Note that amnestic Cycloheximide doses are much lower in rats (1-3 mg/kg) than in mice, consistent with a similar difference in LD50s for rats and mice. Cycloheximide doses of 120-150 mg/kg result in approximately 95% inhibition of brain protein synthesis as measured 30-60 min after injection; the dose of 30 mg/kg produces approximately 80% inhibition of brain protein synthesis.
    Rats[3]
    Unilateral carotid artery ligation is performed in 7-day old Sprague Dawley rat pups under methoxyflurane anesthesia. The neck is incised in the midline, and the right common carotid artery is permanently ligated with 4-0 silk. Total time of surgery in each animal never exceeded 5 min. Following surgery, rats are returned to their mother for recovery and feeding for 2 hr. The pups are then exposed to a 100 min-period of hypoxia (8% O2, 92% N2) by placing them in an airtight chamber partially submerged in a temperature controlled water bath to maintain the ambient temperature inside the chamber at a constant 36°C. In the HI with Cycloheximide treatment group, the rat pups receive an intraperitoneal injection of Cycloheximide at a dose of 0.6 mg/kg at 0, 6, 12 or 24 hr of recovery, and an equal volume of normal saline is given to a HI control group. Then, the rat pups are returned to their dam until sacrifice; the whole brain tissue is obtained under deep pentobarbital anesthesia (60 mg/kg, intraperitoneal) for flow cytometry and triphenyl tetrazolium chloride (TTC) at 48 and 72 hr after HI, respectively.

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.
    参考文献

    Purity: 99.86%

    COA (248 KB) HNMR (210 KB) LCMS (133 KB)

    产品使用指南 (1538 KB)

    • 摩尔计算器

    • 稀释计算器

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    质量   浓度   体积   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
    × = ×
    C1   V1   C2   V2

    Keywords:

    Cycloheximide66-81-9Actidione Naramycin ADNA/RNA SynthesisFungalAutophagyFerroptosisAntibioticantibioticeukaryoteproteinsynthesisInhibitorinhibitorinhibit

    您最近查看的产品:

    Your information is safe with us. * Required Fields.

       产品名称：

    		  

    * 需求量：

    * 客户姓名：

    		 

    * Email：

    * 电话：

    		 

    * 公司或机构名称：

       留言给我们：

    Bulk Inquiry

    Inquiry Information

    产品名称：
    Cycloheximide
    目录号：
    HY-12320
    需求量：

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

       产品名称：

    		  

    * Lot #：

    * 客户姓名：

    		 

    * Email：

       电话：

    		 

    * 部门：

    * 公司或机构名称：

    		 

       留言给我们：

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.